CAS: 2307249-33-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BAY885 REF: AN-AG01EO7ACAS: 2307249-33-6 | 99+% | To inquire | Tue 21 May 24 |
 | BAY885 REF: TM-T10479CAS: 2307249-33-6 | 99.83% | 123.00 €~1,138.00 € | Tue 28 May 24 |
 | BAY-885 REF: 3D-HSD24933CAS: 2307249-33-6 | Min. 95% | To inquire | Mon 01 Jul 24 |
Ref: AN-AG01EO7A
| 25mg | 598.00 € | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
BAY885
CAS:2307249-33-6
BAY885 is a new ERK5 inhibitor.
Formula:
C25H28F3N7O2
Purity:
99.83%
Color and Shape:
Solid
Molecular weight:
515.53
Ref: TM-T10479
| 1mg | 123.00 € | |
| 2mg | 171.00 € | |
| 5mg | 270.00 € | |
| 10mg | 432.00 € | |
| 25mg | 833.00 € | |
| 50mg | 1,138.00 € | |
| 1ml*10 (DMSO) | 306.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
BAY-885
CAS:2307249-33-6
BAY-885 is a drug development candidate that has been shown to have potent cytotoxic activity …
Formula:
C25H28F3N7O2
Purity:
Min. 95%
Molecular weight:
515.53 g/mol
Ref: 3D-HSD24933
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
